JP2005526691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526691A5 JP2005526691A5 JP2003519067A JP2003519067A JP2005526691A5 JP 2005526691 A5 JP2005526691 A5 JP 2005526691A5 JP 2003519067 A JP2003519067 A JP 2003519067A JP 2003519067 A JP2003519067 A JP 2003519067A JP 2005526691 A5 JP2005526691 A5 JP 2005526691A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- pyrido
- hexahydro
- indole
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 43
- 125000000217 alkyl group Chemical group 0.000 claims 24
- 229910052739 hydrogen Inorganic materials 0.000 claims 23
- 239000001257 hydrogen Substances 0.000 claims 23
- 125000002947 alkylene group Chemical group 0.000 claims 16
- -1 pyrrolidino, piperidino, morpholino Chemical group 0.000 claims 16
- 150000002431 hydrogen Chemical class 0.000 claims 14
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 12
- 125000001475 halogen functional group Chemical group 0.000 claims 12
- 125000003342 alkenyl group Chemical group 0.000 claims 11
- 125000000304 alkynyl group Chemical group 0.000 claims 11
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 9
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 4
- OGVIBOYOTLEICI-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound ClC1=CC(Cl)=CC=C1C1=CC=C(NC2C3CNCC2)C3=C1 OGVIBOYOTLEICI-UHFFFAOYSA-N 0.000 claims 3
- 208000019901 Anxiety disease Diseases 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 230000036506 anxiety Effects 0.000 claims 3
- 210000003169 central nervous system Anatomy 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims 2
- 125000005505 thiomorpholino group Chemical group 0.000 claims 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims 2
- ZTYHSDRSYGQVQL-LRDDRELGSA-N (4as,9br)-8-(2,6-difluorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound FC1=CC=CC(F)=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 ZTYHSDRSYGQVQL-LRDDRELGSA-N 0.000 claims 1
- ZQDRUWSNYLOVNO-LRDDRELGSA-N (4as,9br)-8-(2-chloro-6-fluorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound FC1=CC=CC(Cl)=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 ZQDRUWSNYLOVNO-LRDDRELGSA-N 0.000 claims 1
- MVTKBQFDSSHVNM-YOEHRIQHSA-N (4as,9br)-8-(2-chlorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound ClC1=CC=CC=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 MVTKBQFDSSHVNM-YOEHRIQHSA-N 0.000 claims 1
- LABIXCLHTUFPJV-YOEHRIQHSA-N (4as,9br)-8-(2-fluorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound FC1=CC=CC=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 LABIXCLHTUFPJV-YOEHRIQHSA-N 0.000 claims 1
- DRFSSWQOSCBTHN-HKUYNNGSSA-N (4as,9br)-8-(4-methoxy-2-methylphenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound CC1=CC(OC)=CC=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 DRFSSWQOSCBTHN-HKUYNNGSSA-N 0.000 claims 1
- ICBBYUYDXRQZBG-YOEHRIQHSA-N (4as,9br)-8-[2-(trifluoromethyl)phenyl]-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound FC(F)(F)C1=CC=CC=C1C1=CC=C(N[C@@H]2[C@H]3CNCC2)C3=C1 ICBBYUYDXRQZBG-YOEHRIQHSA-N 0.000 claims 1
- UAAXYVDHKWEKNN-RDJZCZTQSA-N (4as,9br)-8-phenyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound N([C@H]1CCNC[C@H]1C1=C2)C1=CC=C2C1=CC=CC=C1 UAAXYVDHKWEKNN-RDJZCZTQSA-N 0.000 claims 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 claims 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims 1
- PMZMPGDSRIYTDF-UHFFFAOYSA-N 6-bromo-8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound ClC1=CC(Cl)=CC=C1C(C=C1Br)=CC2=C1NC1CCNCC12 PMZMPGDSRIYTDF-UHFFFAOYSA-N 0.000 claims 1
- GOLLOHUQKXWFKV-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5,6-diethyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C(CC)=C2N(CC)C3CCNCC3C2=CC=1C1=CC=C(Cl)C=C1Cl GOLLOHUQKXWFKV-UHFFFAOYSA-N 0.000 claims 1
- GCJDLXQTLDPCFC-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5,6-dimethyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C(C)=C2N(C)C3CCNCC3C2=CC=1C1=CC=C(Cl)C=C1Cl GCJDLXQTLDPCFC-UHFFFAOYSA-N 0.000 claims 1
- ZLWRJYNAJAAJLC-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5-ethyl-6-methyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C(C)=C2N(CC)C3CCNCC3C2=CC=1C1=CC=C(Cl)C=C1Cl ZLWRJYNAJAAJLC-UHFFFAOYSA-N 0.000 claims 1
- JWLDTNNDEQVTJW-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5-ethyl-6-methylsulfanyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C(SC)=C2N(CC)C3CCNCC3C2=CC=1C1=CC=C(Cl)C=C1Cl JWLDTNNDEQVTJW-UHFFFAOYSA-N 0.000 claims 1
- XDSDUPZHGOCMLH-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5-methyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C=C2N(C)C3CCNCC3C2=CC=1C1=CC=C(Cl)C=C1Cl XDSDUPZHGOCMLH-UHFFFAOYSA-N 0.000 claims 1
- GHKAKMOGXIBCFD-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-5-methyl-6-methylsulfanyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3N(C)C=2C(SC)=CC=1C1=CC=C(Cl)C=C1Cl GHKAKMOGXIBCFD-UHFFFAOYSA-N 0.000 claims 1
- MSNUFJDXDJRDCQ-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-6-ethyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3NC=2C(CC)=CC=1C1=CC=C(Cl)C=C1Cl MSNUFJDXDJRDCQ-UHFFFAOYSA-N 0.000 claims 1
- MRAWTCZLQZPPBQ-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-6-ethyl-5-methyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3N(C)C=2C(CC)=CC=1C1=CC=C(Cl)C=C1Cl MRAWTCZLQZPPBQ-UHFFFAOYSA-N 0.000 claims 1
- YIDOGYZMYJLNBP-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-6-ethylsulfanyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3NC=2C(SCC)=CC=1C1=CC=C(Cl)C=C1Cl YIDOGYZMYJLNBP-UHFFFAOYSA-N 0.000 claims 1
- YUZGGVHIVJQNQJ-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-6-ethylsulfanyl-5-methyl-1,2,3,4,4a,9b-hexahydropyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3N(C)C=2C(SCC)=CC=1C1=CC=C(Cl)C=C1Cl YUZGGVHIVJQNQJ-UHFFFAOYSA-N 0.000 claims 1
- LRANPAICFTUZGK-UHFFFAOYSA-N 8-(2,4-dichlorophenyl)-6-methylsulfanyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole Chemical compound C=1C=2C3CNCCC3NC=2C(SC)=CC=1C1=CC=C(Cl)C=C1Cl LRANPAICFTUZGK-UHFFFAOYSA-N 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31089001P | 2001-08-08 | 2001-08-08 | |
| PCT/US2002/025130 WO2003014118A1 (en) | 2001-08-08 | 2002-08-06 | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526691A JP2005526691A (ja) | 2005-09-08 |
| JP2005526691A5 true JP2005526691A5 (https=) | 2006-01-05 |
Family
ID=23204521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003519067A Withdrawn JP2005526691A (ja) | 2001-08-08 | 2002-08-06 | 治療剤１Ｈ−ピリド［４，３−ｂ］インドール |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6849640B2 (https=) |
| EP (1) | EP1414819B1 (https=) |
| JP (1) | JP2005526691A (https=) |
| AT (1) | ATE306486T1 (https=) |
| BR (1) | BR0211608A (https=) |
| CA (1) | CA2453537A1 (https=) |
| DE (1) | DE60206636T2 (https=) |
| ES (1) | ES2250689T3 (https=) |
| MX (1) | MXPA04001203A (https=) |
| WO (1) | WO2003014118A1 (https=) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002066494A2 (en) * | 2001-02-16 | 2002-08-29 | Bristol-Myers Squibb Company | Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| WO2004056324A2 (en) * | 2002-12-19 | 2004-07-08 | Bristol-Myers Squibb Company | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
| US20080075885A1 (en) * | 2003-08-19 | 2008-03-27 | Heng-Yong Nie | Method of Controllable Morphology of Self-Assembled Monolayers on Substrates |
| WO2005095396A1 (en) * | 2004-03-05 | 2005-10-13 | Pharma C S.A. | 8-phenoxy-ϝ carboline derivatives |
| US7592454B2 (en) | 2004-04-14 | 2009-09-22 | Bristol-Myers Squibb Company | Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists |
| JP5173190B2 (ja) | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
| KR20080034171A (ko) * | 2005-07-28 | 2008-04-18 | 브리스톨-마이어스 스큅 컴퍼니 | 세로토닌 수용체 효능제 및 길항제로서의 치환된테트라히드로-1ｈ-피리도[4,3,ｂ]인돌 |
| US20070117834A1 (en) * | 2005-10-04 | 2007-05-24 | David Hung | Methods and compositions for treating Huntington's disease |
| RU2338537C2 (ru) * | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| RU2329044C1 (ru) * | 2006-11-16 | 2008-07-20 | Андрей Александрович Иващенко | Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство |
| KR102107954B1 (ko) * | 2007-03-12 | 2020-05-07 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| RU2338745C1 (ru) * | 2007-03-21 | 2008-11-20 | Андрей Александрович Иващенко | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
| MX2009012788A (es) * | 2007-05-25 | 2010-01-14 | Medivation Neurology Inc | Metodos y composiciones para estimular celulas. |
| MX2010001218A (es) * | 2007-08-01 | 2010-04-07 | Medivation Neurology Inc | Metodos y composiciones para tratamiento contra esquizofrenia mediante uso de terapia combinada de agentes antipsicoticos. |
| RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
| EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
| KR101614723B1 (ko) | 2008-01-11 | 2016-04-22 | 알바니 몰레큘라 리써치, 인크. | Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌 |
| US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| WO2010036998A2 (en) | 2008-09-29 | 2010-04-01 | Abbott Laboratories | Indole and indoline derivatives and methods of use thereof |
| CA2748813C (en) * | 2009-01-09 | 2018-07-10 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9162980B2 (en) | 2009-01-09 | 2015-10-20 | Board Of Regents Of The University Of Texas System | Anti-depression compounds |
| US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9962368B2 (en) | 2009-01-09 | 2018-05-08 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| EP2424366B1 (en) | 2009-04-29 | 2016-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b]indoles and methods of use |
| CA2760541A1 (en) * | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido[4,3-b] indoles and methods of use |
| JP2012532144A (ja) | 2009-07-01 | 2012-12-13 | アルバニー モレキュラー リサーチ， インコーポレイテッド | アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用 |
| US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| US8618299B2 (en) | 2009-07-01 | 2013-12-31 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
| WO2011014695A1 (en) * | 2009-07-29 | 2011-02-03 | Medivation Technologies, Inc. | New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b] indoles and methods of use |
| US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
| US8809532B2 (en) | 2009-12-17 | 2014-08-19 | Abbvie Inc. | Aza-ring fused indole and indoline derivatives |
| CA2804161A1 (en) | 2010-07-07 | 2012-01-12 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
| US8697700B2 (en) | 2010-12-21 | 2014-04-15 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof |
| EP2668191A4 (en) | 2011-01-19 | 2014-08-20 | Albany Molecular Res Inc | BENZOFURO- [3,2-C-] PYRIDINES AND RELATED ANALOGS AS SEROTONIN-SUBTYPE-6 (5-HT6) MODULATORS FOR THE TREATMENT OF ADIPOSITAS, METABOLISM SYNDROME, COGNITION AND SCHIZOPHRENIA |
| US8791132B2 (en) | 2011-02-18 | 2014-07-29 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| KR20140146192A (ko) | 2012-04-14 | 2014-12-24 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| CA2882826A1 (en) | 2012-08-24 | 2014-02-27 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9708322B2 (en) | 2013-03-15 | 2017-07-18 | Intra-Cellular Therapies, Inc. | Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity |
| WO2015070237A1 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective chemicals and methods for identifying and using same |
| EP3068388A4 (en) | 2013-11-11 | 2017-04-12 | Board of Regents of the University of Texas System | Neuroprotective compounds and use thereof |
| KR102373288B1 (ko) | 2013-12-03 | 2022-03-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| US10077267B2 (en) | 2014-04-04 | 2018-09-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CA2944755A1 (en) | 2014-04-04 | 2015-10-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| TW201710258A (zh) | 2015-06-23 | 2017-03-16 | 碩騰服務公司 | 咔啉抗寄生蟲藥 |
| PL3838274T3 (pl) | 2016-01-26 | 2024-04-02 | Intra-Cellular Therapies, Inc. | Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN |
| DK3407889T3 (da) | 2016-03-25 | 2021-08-09 | Intra Cellular Therapies Inc | Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet |
| US10682354B2 (en) | 2016-03-28 | 2020-06-16 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| EP3525763B1 (en) | 2016-10-12 | 2025-03-05 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| EP3562484B1 (en) | 2016-12-29 | 2021-08-25 | Intra-Cellular Therapies, Inc. | Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders |
| WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| RU2767410C2 (ru) | 2017-03-24 | 2022-03-17 | Интра-Селлулар Терапиз, Инк. | Новые композиции и способы |
| EP3658144B1 (en) | 2017-07-26 | 2022-01-26 | Intra-Cellular Therapies, Inc. | Pyridopyrroloquinoxaline compounds, their compositions and uses in therapy |
| WO2019023062A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
| CN112040940A (zh) | 2018-03-23 | 2020-12-04 | 细胞内治疗公司 | 有机化合物 |
| EP3801527B1 (en) | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| US12144808B2 (en) | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| WO2020047408A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| BR112021003655A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
| US12195463B2 (en) | 2018-12-21 | 2025-01-14 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2021007245A1 (en) | 2019-07-07 | 2021-01-14 | Intra-Cellular Therapies, Inc. | Novel methods |
| EP4072554A4 (en) | 2019-12-11 | 2023-12-20 | Intra-Cellular Therapies, Inc. | ORGANIC CONNECTION |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US57325A (en) * | 1866-08-21 | Improvement in mite ring-machines | ||
| US337250A (en) * | 1886-03-02 | Weather-strip for doors | ||
| US478750A (en) * | 1892-07-12 | Printing-block | ||
| US3657254A (en) * | 1969-10-31 | 1972-04-18 | Nikolai Konstantinovich Barkov | 3 6-dimethyl-1 2 3 4 4a 9a-hexahydro-gamma-carboline dihydrochloride |
| US4337250A (en) | 1979-07-30 | 1982-06-29 | Pfizer Inc. | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents |
| EP0028381B1 (en) | 1979-11-02 | 1985-04-10 | Sandoz Ag | Azepinoindoles, process for their production and pharmaceutical compositions containing them |
| CH649553A5 (de) * | 1982-05-06 | 1985-05-31 | Sandoz Ag | Azepinoindole und verfahren zu deren herstellung. |
| JPS63163347A (ja) | 1986-12-25 | 1988-07-06 | Konica Corp | 有機着色物質の光褪色防止方法 |
| DE68926553T2 (de) * | 1988-08-02 | 1996-10-17 | Glaxo Group Ltd., London | Lactamderivate |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| GB8904551D0 (en) | 1989-02-28 | 1989-04-12 | Glaxo Group Ltd | Chemical compounds |
| JP3108483B2 (ja) * | 1991-09-30 | 2000-11-13 | 日清製粉株式会社 | インドール誘導体およびこれを有効成分とする抗潰瘍薬 |
| GB9226537D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| DE69531476T2 (de) | 1994-09-12 | 2004-06-09 | Lilly Industries Ltd., Basingstoke | Serotonergische Modulatoren |
| TW470745B (en) | 1996-05-23 | 2002-01-01 | Janssen Pharmaceutica Nv | Hexahydro-pyrido[4,3-b]indole derivatives |
| ATE252572T1 (de) | 1998-06-30 | 2003-11-15 | Lilly Co Eli | 5-ht1f agonisten |
| WO2002024700A2 (en) * | 2000-09-20 | 2002-03-28 | Pharmacia & Upjohn Company | SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
-
2002
- 2002-08-06 CA CA002453537A patent/CA2453537A1/en not_active Abandoned
- 2002-08-06 US US10/214,405 patent/US6849640B2/en not_active Expired - Fee Related
- 2002-08-06 WO PCT/US2002/025130 patent/WO2003014118A1/en not_active Ceased
- 2002-08-06 DE DE60206636T patent/DE60206636T2/de not_active Expired - Fee Related
- 2002-08-06 MX MXPA04001203A patent/MXPA04001203A/es unknown
- 2002-08-06 EP EP02757023A patent/EP1414819B1/en not_active Expired - Lifetime
- 2002-08-06 JP JP2003519067A patent/JP2005526691A/ja not_active Withdrawn
- 2002-08-06 ES ES02757023T patent/ES2250689T3/es not_active Expired - Lifetime
- 2002-08-06 BR BRPI0211608-1A patent/BR0211608A/pt not_active IP Right Cessation
- 2002-08-06 AT AT02757023T patent/ATE306486T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005526691A5 (https=) | ||
| RU2219178C2 (ru) | Бициклические производные, фармацевтическая композиция на их основе и промежуточные соединения | |
| AU776077B2 (en) | Use of CRF antagonists and related compositions | |
| RU2000110738A (ru) | Бициклические ингибиторы киназ | |
| JP2004528312A5 (https=) | ||
| ES2761423T3 (es) | Compuestos para tratar la atrofia muscular espinal | |
| JP5666910B2 (ja) | 認知機能障害を治療するためのキット、組成物、製品もしくは医薬 | |
| CA2556160A1 (en) | Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists | |
| JP2005507878A5 (https=) | ||
| RU2002104935A (ru) | ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА | |
| NO20044974L (no) | Imidazo [1,2-a]pyrazin-8-ylaminer, fremgangsmater for fremstilling og anvendelse derav | |
| EP3349757A1 (en) | Modulators of toll-like recptors for the treatment of hiv | |
| RU2008144584A (ru) | 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний | |
| JP2020504136A5 (https=) | ||
| JP2009524676A5 (https=) | ||
| HRP20160036T1 (hr) | Određeni kemijski entiteti, priprave i metode koji sadrže imidazopirimidin | |
| HRP20140641T1 (hr) | Kondenzirani imidazoli i sastavi koji ih sadrže za lijeäśenje parazitnih bolesti kao što je primjerice malarija | |
| TW201028422A (en) | Amino-heterocyclic compounds | |
| JP2004091490A (ja) | 勃起機能不全の治療のためのｃＧＭＰ−ＰＤＥ阻害薬 | |
| RU2008109914A (ru) | Применение производных тиенопиридона в качестве активаторов амфк и фармацевтические композиции, которые их содержат | |
| JP2005508955A5 (https=) | ||
| HRP20150235T1 (hr) | Derivati pirimidina, njihovo dobivanje i njihova farmaceutska upotreba | |
| RU2005136166A (ru) | 2-алкинил -и 2-алкенил-пиразол-[4, 3-е]-1. 2. 4-триазоло-[1. 5-с]-пиримидиновые антагонисты а рецептора аденозина | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| JP2019524844A5 (https=) |